findmyKOL

Frances Wallach, MD

Basic profile

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Frances Wallach is an Infectious Disease physician affiliated with Donald & Barbara Zucker School of Medicine at Hofstra/Northwell. OpenAlex indexes 52 publications with 1,351 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
52publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,351citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

One Gustave L. Levy Place
New York, NY 10029

Telephone

212-241-6741

Registry record last updated 6 Dec 2010.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    46.9%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor18.3%
    Juluca32%Dovato29%Tivicay15%Isentress14%Cabenuva11%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor5.3%
    Descovy77%Abacavir24%
    Part D<11 patients

    + 11 more classes in this area

  • Cardiovascular

    40.7%
    Statin18.8%
    Atorvastatin Calcium83%Rosuvastatin Calcium9%Pravastatin Sodium8%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)9.1%
    Olmesartan-Hydrochlorothiazide42%Losartan Potassium36%Losartan-Hydrochlorothiazide22%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    4.9%
    Serotonin-3 Receptor Antagonist1.8%
    Ondansetron Hcl100%
    Part D<11 patients
    Provitamin D2 Compound1.7%
    Vitamin D2100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)85.1% facility · 14.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”